WHO Needs to Reform Accountability Systems to Prevent Sexual Exploitation and Abuse 28/01/2022 Elaine Ruth Fletcher & Raisa Santos WHO needs to reform lines of authority and responsibility across all aspects of its emergencies response operations in order to effectively prevent, report, and take measures against sexual exploitation and harrassment. Those were the highlights of a final report by an Independent Oversight Advisory Committee (IOAC) of the WHO Health Emergencies Programme, examining the claims […] Continue reading -> Developing Countries Pledge to Combat Diabetes and Obesity; China & Thailand Suggest Global Targets Are Too Ambitious 27/01/2022 Paul Adepoju In a long and winding discussion Thursday at The World Health Organization’s Executive Board, low- and middle-income countries (LMICs) pledged to redouble their efforts against noncommunicable diseases (NCDs), such as diabetes and obesity, which are having increasing impacts on health and well-being – in addition to infectious diseases that have been at the forefront of […] Continue reading -> WHO Accused of Relenting to Alcohol Lobby in Action Plan to Battle ‘Harmful Use’ and Risks of Noncommunicable Disease 27/01/2022 Kerry Cullinan Only 14 countries are on track to achieve the Sustainable Development Goals to reduce premature mortality from non-communicable diseases (NCDs) by one third by 2030, the World Health Organization (WHO) revealed at its executive board meeting on Wednesday. After listening for over three hours to countries’ views on the WHO roadmap 2023–2030 to prevent and […] Continue reading -> Africa Calls for ‘Radical Disruption’ of WHO Funding, as EU Wants More Efficiency 24/01/2022 Kerry Cullinan Unless a future pandemic ‘instrument’ is properly financed and legally binding, it will not be able to prevent health emergencies, numerous member states told the World Health Organization’s (WHO) 150th executive board meeting on Monday. Speaking on behalf of Africa’s 47 member states, Kenya’s Dr Cleopa Mailu said there should be a “radical disruption” of […] Continue reading -> Will Omicron Offer a COVID-19 Reprieve? Experts are Divided 24/01/2022 Maayan Hoffman Experts are divided on whether or not Omicron could offer a COVID-19 reprieve. As the Omicron wave hits its peak in parts of the world, leaving more people infected than in any previous outbreak, some scientists believe that respite is on the way, while others argue another variant could emerge that will be even more […] Continue reading -> As WHO Executive Board Meets – Handful of Countries Stall Plans to Reform WHO Finance 23/01/2022 Elaine Ruth Fletcher As the World Health Organization’s executive board meets this week, two major issues – reforming its finances and pandemic response – continue to defy easy consensus. A handful of powerful countries, including but not limited to the United States, remain hesitant over a plan to bolster the World Health Organization’s (WHO) finances by increasing member […] Continue reading -> Mixed Reaction in Africa to WHO’s New Position on Booster Shots 22/01/2022 Paul Adepoju IDABAN, Nigeria – The decision of the World Health Organization (WHO) to drop its opposition for COVID-19 vaccination booster shots has raised concerns in Africa about the potential depletion of COVID-19 vaccine doses available to African countries. On Friday, Health Policy Watch reported WHO recommended the wider administration of a third shot of the Pfizer-BioNTech […] Continue reading -> WHO Drops Opposition to Boosters – Recommends Third Pfizer Jab for Adults & Two Vaccines for Children Ages 5 & Up 21/01/2022 Elaine Ruth Fletcher In a stark departure from months of booster opposition, WHO on Friday recommended the wider administration of a third shot of the Pfizer-BioNTech mRNA vaccine – as well as jabs for children age 5 and older. The recommendation comes after over 120 countries already have booster campaigns in full-swing, some of them beginning as early […] Continue reading -> Italian Lab Study Finds Sputnik V Beat Pfizer’s mRNA Vaccine Against Omicron – Yielding Higher Antibody Levels 21/01/2022 Maayan Hoffman Russia’s Sputnik V demonstrated more than two times higher virus neutralizing activity against the Omicron variant in comparison to the Pfizer coronavirus vaccine, according to a study of blood samples, released Thursday by the National Institute for Infectious Diseases Lazzaro Spallanzani in Italy and Russia’s Gamaleya Center. The research was prepared by a team of […] Continue reading -> Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> Posts navigation Older postsNewer posts
Developing Countries Pledge to Combat Diabetes and Obesity; China & Thailand Suggest Global Targets Are Too Ambitious 27/01/2022 Paul Adepoju In a long and winding discussion Thursday at The World Health Organization’s Executive Board, low- and middle-income countries (LMICs) pledged to redouble their efforts against noncommunicable diseases (NCDs), such as diabetes and obesity, which are having increasing impacts on health and well-being – in addition to infectious diseases that have been at the forefront of […] Continue reading -> WHO Accused of Relenting to Alcohol Lobby in Action Plan to Battle ‘Harmful Use’ and Risks of Noncommunicable Disease 27/01/2022 Kerry Cullinan Only 14 countries are on track to achieve the Sustainable Development Goals to reduce premature mortality from non-communicable diseases (NCDs) by one third by 2030, the World Health Organization (WHO) revealed at its executive board meeting on Wednesday. After listening for over three hours to countries’ views on the WHO roadmap 2023–2030 to prevent and […] Continue reading -> Africa Calls for ‘Radical Disruption’ of WHO Funding, as EU Wants More Efficiency 24/01/2022 Kerry Cullinan Unless a future pandemic ‘instrument’ is properly financed and legally binding, it will not be able to prevent health emergencies, numerous member states told the World Health Organization’s (WHO) 150th executive board meeting on Monday. Speaking on behalf of Africa’s 47 member states, Kenya’s Dr Cleopa Mailu said there should be a “radical disruption” of […] Continue reading -> Will Omicron Offer a COVID-19 Reprieve? Experts are Divided 24/01/2022 Maayan Hoffman Experts are divided on whether or not Omicron could offer a COVID-19 reprieve. As the Omicron wave hits its peak in parts of the world, leaving more people infected than in any previous outbreak, some scientists believe that respite is on the way, while others argue another variant could emerge that will be even more […] Continue reading -> As WHO Executive Board Meets – Handful of Countries Stall Plans to Reform WHO Finance 23/01/2022 Elaine Ruth Fletcher As the World Health Organization’s executive board meets this week, two major issues – reforming its finances and pandemic response – continue to defy easy consensus. A handful of powerful countries, including but not limited to the United States, remain hesitant over a plan to bolster the World Health Organization’s (WHO) finances by increasing member […] Continue reading -> Mixed Reaction in Africa to WHO’s New Position on Booster Shots 22/01/2022 Paul Adepoju IDABAN, Nigeria – The decision of the World Health Organization (WHO) to drop its opposition for COVID-19 vaccination booster shots has raised concerns in Africa about the potential depletion of COVID-19 vaccine doses available to African countries. On Friday, Health Policy Watch reported WHO recommended the wider administration of a third shot of the Pfizer-BioNTech […] Continue reading -> WHO Drops Opposition to Boosters – Recommends Third Pfizer Jab for Adults & Two Vaccines for Children Ages 5 & Up 21/01/2022 Elaine Ruth Fletcher In a stark departure from months of booster opposition, WHO on Friday recommended the wider administration of a third shot of the Pfizer-BioNTech mRNA vaccine – as well as jabs for children age 5 and older. The recommendation comes after over 120 countries already have booster campaigns in full-swing, some of them beginning as early […] Continue reading -> Italian Lab Study Finds Sputnik V Beat Pfizer’s mRNA Vaccine Against Omicron – Yielding Higher Antibody Levels 21/01/2022 Maayan Hoffman Russia’s Sputnik V demonstrated more than two times higher virus neutralizing activity against the Omicron variant in comparison to the Pfizer coronavirus vaccine, according to a study of blood samples, released Thursday by the National Institute for Infectious Diseases Lazzaro Spallanzani in Italy and Russia’s Gamaleya Center. The research was prepared by a team of […] Continue reading -> Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> Posts navigation Older postsNewer posts
WHO Accused of Relenting to Alcohol Lobby in Action Plan to Battle ‘Harmful Use’ and Risks of Noncommunicable Disease 27/01/2022 Kerry Cullinan Only 14 countries are on track to achieve the Sustainable Development Goals to reduce premature mortality from non-communicable diseases (NCDs) by one third by 2030, the World Health Organization (WHO) revealed at its executive board meeting on Wednesday. After listening for over three hours to countries’ views on the WHO roadmap 2023–2030 to prevent and […] Continue reading -> Africa Calls for ‘Radical Disruption’ of WHO Funding, as EU Wants More Efficiency 24/01/2022 Kerry Cullinan Unless a future pandemic ‘instrument’ is properly financed and legally binding, it will not be able to prevent health emergencies, numerous member states told the World Health Organization’s (WHO) 150th executive board meeting on Monday. Speaking on behalf of Africa’s 47 member states, Kenya’s Dr Cleopa Mailu said there should be a “radical disruption” of […] Continue reading -> Will Omicron Offer a COVID-19 Reprieve? Experts are Divided 24/01/2022 Maayan Hoffman Experts are divided on whether or not Omicron could offer a COVID-19 reprieve. As the Omicron wave hits its peak in parts of the world, leaving more people infected than in any previous outbreak, some scientists believe that respite is on the way, while others argue another variant could emerge that will be even more […] Continue reading -> As WHO Executive Board Meets – Handful of Countries Stall Plans to Reform WHO Finance 23/01/2022 Elaine Ruth Fletcher As the World Health Organization’s executive board meets this week, two major issues – reforming its finances and pandemic response – continue to defy easy consensus. A handful of powerful countries, including but not limited to the United States, remain hesitant over a plan to bolster the World Health Organization’s (WHO) finances by increasing member […] Continue reading -> Mixed Reaction in Africa to WHO’s New Position on Booster Shots 22/01/2022 Paul Adepoju IDABAN, Nigeria – The decision of the World Health Organization (WHO) to drop its opposition for COVID-19 vaccination booster shots has raised concerns in Africa about the potential depletion of COVID-19 vaccine doses available to African countries. On Friday, Health Policy Watch reported WHO recommended the wider administration of a third shot of the Pfizer-BioNTech […] Continue reading -> WHO Drops Opposition to Boosters – Recommends Third Pfizer Jab for Adults & Two Vaccines for Children Ages 5 & Up 21/01/2022 Elaine Ruth Fletcher In a stark departure from months of booster opposition, WHO on Friday recommended the wider administration of a third shot of the Pfizer-BioNTech mRNA vaccine – as well as jabs for children age 5 and older. The recommendation comes after over 120 countries already have booster campaigns in full-swing, some of them beginning as early […] Continue reading -> Italian Lab Study Finds Sputnik V Beat Pfizer’s mRNA Vaccine Against Omicron – Yielding Higher Antibody Levels 21/01/2022 Maayan Hoffman Russia’s Sputnik V demonstrated more than two times higher virus neutralizing activity against the Omicron variant in comparison to the Pfizer coronavirus vaccine, according to a study of blood samples, released Thursday by the National Institute for Infectious Diseases Lazzaro Spallanzani in Italy and Russia’s Gamaleya Center. The research was prepared by a team of […] Continue reading -> Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> Posts navigation Older postsNewer posts
Africa Calls for ‘Radical Disruption’ of WHO Funding, as EU Wants More Efficiency 24/01/2022 Kerry Cullinan Unless a future pandemic ‘instrument’ is properly financed and legally binding, it will not be able to prevent health emergencies, numerous member states told the World Health Organization’s (WHO) 150th executive board meeting on Monday. Speaking on behalf of Africa’s 47 member states, Kenya’s Dr Cleopa Mailu said there should be a “radical disruption” of […] Continue reading -> Will Omicron Offer a COVID-19 Reprieve? Experts are Divided 24/01/2022 Maayan Hoffman Experts are divided on whether or not Omicron could offer a COVID-19 reprieve. As the Omicron wave hits its peak in parts of the world, leaving more people infected than in any previous outbreak, some scientists believe that respite is on the way, while others argue another variant could emerge that will be even more […] Continue reading -> As WHO Executive Board Meets – Handful of Countries Stall Plans to Reform WHO Finance 23/01/2022 Elaine Ruth Fletcher As the World Health Organization’s executive board meets this week, two major issues – reforming its finances and pandemic response – continue to defy easy consensus. A handful of powerful countries, including but not limited to the United States, remain hesitant over a plan to bolster the World Health Organization’s (WHO) finances by increasing member […] Continue reading -> Mixed Reaction in Africa to WHO’s New Position on Booster Shots 22/01/2022 Paul Adepoju IDABAN, Nigeria – The decision of the World Health Organization (WHO) to drop its opposition for COVID-19 vaccination booster shots has raised concerns in Africa about the potential depletion of COVID-19 vaccine doses available to African countries. On Friday, Health Policy Watch reported WHO recommended the wider administration of a third shot of the Pfizer-BioNTech […] Continue reading -> WHO Drops Opposition to Boosters – Recommends Third Pfizer Jab for Adults & Two Vaccines for Children Ages 5 & Up 21/01/2022 Elaine Ruth Fletcher In a stark departure from months of booster opposition, WHO on Friday recommended the wider administration of a third shot of the Pfizer-BioNTech mRNA vaccine – as well as jabs for children age 5 and older. The recommendation comes after over 120 countries already have booster campaigns in full-swing, some of them beginning as early […] Continue reading -> Italian Lab Study Finds Sputnik V Beat Pfizer’s mRNA Vaccine Against Omicron – Yielding Higher Antibody Levels 21/01/2022 Maayan Hoffman Russia’s Sputnik V demonstrated more than two times higher virus neutralizing activity against the Omicron variant in comparison to the Pfizer coronavirus vaccine, according to a study of blood samples, released Thursday by the National Institute for Infectious Diseases Lazzaro Spallanzani in Italy and Russia’s Gamaleya Center. The research was prepared by a team of […] Continue reading -> Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> Posts navigation Older postsNewer posts
Will Omicron Offer a COVID-19 Reprieve? Experts are Divided 24/01/2022 Maayan Hoffman Experts are divided on whether or not Omicron could offer a COVID-19 reprieve. As the Omicron wave hits its peak in parts of the world, leaving more people infected than in any previous outbreak, some scientists believe that respite is on the way, while others argue another variant could emerge that will be even more […] Continue reading -> As WHO Executive Board Meets – Handful of Countries Stall Plans to Reform WHO Finance 23/01/2022 Elaine Ruth Fletcher As the World Health Organization’s executive board meets this week, two major issues – reforming its finances and pandemic response – continue to defy easy consensus. A handful of powerful countries, including but not limited to the United States, remain hesitant over a plan to bolster the World Health Organization’s (WHO) finances by increasing member […] Continue reading -> Mixed Reaction in Africa to WHO’s New Position on Booster Shots 22/01/2022 Paul Adepoju IDABAN, Nigeria – The decision of the World Health Organization (WHO) to drop its opposition for COVID-19 vaccination booster shots has raised concerns in Africa about the potential depletion of COVID-19 vaccine doses available to African countries. On Friday, Health Policy Watch reported WHO recommended the wider administration of a third shot of the Pfizer-BioNTech […] Continue reading -> WHO Drops Opposition to Boosters – Recommends Third Pfizer Jab for Adults & Two Vaccines for Children Ages 5 & Up 21/01/2022 Elaine Ruth Fletcher In a stark departure from months of booster opposition, WHO on Friday recommended the wider administration of a third shot of the Pfizer-BioNTech mRNA vaccine – as well as jabs for children age 5 and older. The recommendation comes after over 120 countries already have booster campaigns in full-swing, some of them beginning as early […] Continue reading -> Italian Lab Study Finds Sputnik V Beat Pfizer’s mRNA Vaccine Against Omicron – Yielding Higher Antibody Levels 21/01/2022 Maayan Hoffman Russia’s Sputnik V demonstrated more than two times higher virus neutralizing activity against the Omicron variant in comparison to the Pfizer coronavirus vaccine, according to a study of blood samples, released Thursday by the National Institute for Infectious Diseases Lazzaro Spallanzani in Italy and Russia’s Gamaleya Center. The research was prepared by a team of […] Continue reading -> Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> Posts navigation Older postsNewer posts
As WHO Executive Board Meets – Handful of Countries Stall Plans to Reform WHO Finance 23/01/2022 Elaine Ruth Fletcher As the World Health Organization’s executive board meets this week, two major issues – reforming its finances and pandemic response – continue to defy easy consensus. A handful of powerful countries, including but not limited to the United States, remain hesitant over a plan to bolster the World Health Organization’s (WHO) finances by increasing member […] Continue reading -> Mixed Reaction in Africa to WHO’s New Position on Booster Shots 22/01/2022 Paul Adepoju IDABAN, Nigeria – The decision of the World Health Organization (WHO) to drop its opposition for COVID-19 vaccination booster shots has raised concerns in Africa about the potential depletion of COVID-19 vaccine doses available to African countries. On Friday, Health Policy Watch reported WHO recommended the wider administration of a third shot of the Pfizer-BioNTech […] Continue reading -> WHO Drops Opposition to Boosters – Recommends Third Pfizer Jab for Adults & Two Vaccines for Children Ages 5 & Up 21/01/2022 Elaine Ruth Fletcher In a stark departure from months of booster opposition, WHO on Friday recommended the wider administration of a third shot of the Pfizer-BioNTech mRNA vaccine – as well as jabs for children age 5 and older. The recommendation comes after over 120 countries already have booster campaigns in full-swing, some of them beginning as early […] Continue reading -> Italian Lab Study Finds Sputnik V Beat Pfizer’s mRNA Vaccine Against Omicron – Yielding Higher Antibody Levels 21/01/2022 Maayan Hoffman Russia’s Sputnik V demonstrated more than two times higher virus neutralizing activity against the Omicron variant in comparison to the Pfizer coronavirus vaccine, according to a study of blood samples, released Thursday by the National Institute for Infectious Diseases Lazzaro Spallanzani in Italy and Russia’s Gamaleya Center. The research was prepared by a team of […] Continue reading -> Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> Posts navigation Older postsNewer posts
Mixed Reaction in Africa to WHO’s New Position on Booster Shots 22/01/2022 Paul Adepoju IDABAN, Nigeria – The decision of the World Health Organization (WHO) to drop its opposition for COVID-19 vaccination booster shots has raised concerns in Africa about the potential depletion of COVID-19 vaccine doses available to African countries. On Friday, Health Policy Watch reported WHO recommended the wider administration of a third shot of the Pfizer-BioNTech […] Continue reading -> WHO Drops Opposition to Boosters – Recommends Third Pfizer Jab for Adults & Two Vaccines for Children Ages 5 & Up 21/01/2022 Elaine Ruth Fletcher In a stark departure from months of booster opposition, WHO on Friday recommended the wider administration of a third shot of the Pfizer-BioNTech mRNA vaccine – as well as jabs for children age 5 and older. The recommendation comes after over 120 countries already have booster campaigns in full-swing, some of them beginning as early […] Continue reading -> Italian Lab Study Finds Sputnik V Beat Pfizer’s mRNA Vaccine Against Omicron – Yielding Higher Antibody Levels 21/01/2022 Maayan Hoffman Russia’s Sputnik V demonstrated more than two times higher virus neutralizing activity against the Omicron variant in comparison to the Pfizer coronavirus vaccine, according to a study of blood samples, released Thursday by the National Institute for Infectious Diseases Lazzaro Spallanzani in Italy and Russia’s Gamaleya Center. The research was prepared by a team of […] Continue reading -> Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> Posts navigation Older postsNewer posts
WHO Drops Opposition to Boosters – Recommends Third Pfizer Jab for Adults & Two Vaccines for Children Ages 5 & Up 21/01/2022 Elaine Ruth Fletcher In a stark departure from months of booster opposition, WHO on Friday recommended the wider administration of a third shot of the Pfizer-BioNTech mRNA vaccine – as well as jabs for children age 5 and older. The recommendation comes after over 120 countries already have booster campaigns in full-swing, some of them beginning as early […] Continue reading -> Italian Lab Study Finds Sputnik V Beat Pfizer’s mRNA Vaccine Against Omicron – Yielding Higher Antibody Levels 21/01/2022 Maayan Hoffman Russia’s Sputnik V demonstrated more than two times higher virus neutralizing activity against the Omicron variant in comparison to the Pfizer coronavirus vaccine, according to a study of blood samples, released Thursday by the National Institute for Infectious Diseases Lazzaro Spallanzani in Italy and Russia’s Gamaleya Center. The research was prepared by a team of […] Continue reading -> Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> Posts navigation Older postsNewer posts
Italian Lab Study Finds Sputnik V Beat Pfizer’s mRNA Vaccine Against Omicron – Yielding Higher Antibody Levels 21/01/2022 Maayan Hoffman Russia’s Sputnik V demonstrated more than two times higher virus neutralizing activity against the Omicron variant in comparison to the Pfizer coronavirus vaccine, according to a study of blood samples, released Thursday by the National Institute for Infectious Diseases Lazzaro Spallanzani in Italy and Russia’s Gamaleya Center. The research was prepared by a team of […] Continue reading -> Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> Posts navigation Older postsNewer posts
Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> Posts navigation Older postsNewer posts